덱스컴(주)
DE ˙ DB ˙ US2521311074
€62.20 ↓ -0.20 (-0.32%)
2026-06-04
주가
SecurityDE:DC4 / DexCom, Inc.
InstitutionRegions Financial Corp
Latest Disclosed Ownership16,073 shares
Latest Disclosed Value $ 1,009,385
Regions Financial Corp reports 2.40% decrease in ownership of DC4 / DexCom, Inc.

On May 5, 2026 - Regions Financial Corp filed a 13F-HR form disclosing ownership of 16,073 shares of DexCom, Inc. (DE:DC4) valued at $870,996 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 16,468 shares of DexCom, Inc.. This represents a change in shares of -2.40% during the quarter. The current value of the position is $999,741 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F DEXCOM COM 252131107 16,073 -395 -2.40 1,009 -7.60 0.0066
2026-01-27 2025-12-31 13F DEXCOM COM 252131107 16,468 -1,410 -7.89 1,093 -9.23 0.0070
2025-11-19 2025-09-30 13F/A-1 DEXCOM COM 252131107 17,878 -2,554 -12.50 1,203 -32.53 0.0078
2025-11-19 2025-09-30 13F DEXCOM COM 252131107 17,878 -2,554 1,203 0.0069
2025-07-29 2025-06-30 13F DEXCOM COM 252131107 20,432 -7,026 -25.59 1,784 -4.91 0.0123
2025-05-08 2025-03-31 13F DEXCOM COM 252131107 27,458 -4,381 -13.76 1,875 -24.27 0.0140
2025-02-14 2024-12-31 13F Dexcom COM 252131107 31,839 -216,882 -87.20 2,476 -85.15 0.0182
2024-11-14 2024-09-30 13F Dexcom COM 252131107 248,721 -1,590 -0.64 16,674 -41.25 0.1200
2024-07-31 2024-06-30 13F Dexcom COM 252131107 250,311 5,979 2.45 28,380 -16.25 0.2157
2024-04-23 2024-03-31 13F Dexcom COM 252131107 244,332 20,947 9.38 33,889 22.26 0.2572
2024-02-06 2023-12-31 13F Dexcom COM 252131107 223,385 -17,194 -7.15 27,720 23.49 0.2283
2023-11-01 2023-09-30 13F Dexcom COM 252131107 240,579 6,202 2.65 22,446 -25.48 0.2019
2023-08-09 2023-06-30 13F Dexcom COM 252131107 234,377 23,761 11.28 30,120 125,395.83 0.2602
2023-05-12 2023-03-31 13F Dexcom COM 252131107 210,616 157,259 294.73 24 300.00 0.2196
2023-02-06 2022-12-31 13F Dexcom COM 252131107 53,357 -3,443 -6.06 6 -99.87 0.0555
2022-11-03 2022-09-30 13F Dexcom COM 252131107 56,800 -2,134 -3.62 4,575 4.17 0.0461
2022-07-25 2022-06-30 13F Dexcom COM 252131107 58,934 40,900 226.79 4,392 -52.40 0.0418
2022-04-25 2022-03-31 13F Dexcom COM 252131107 18,034 106 0.59 9,226 -4.16 0.0745
2022-01-31 2021-12-31 13F Dexcom COM 252131107 17,928 154 0.87 9,626 -0.97 0.0751
2021-11-04 2021-09-30 13F Dexcom COM 252131107 17,774 -1,457 -7.58 9,720 18.36 0.0840
2021-07-27 2021-06-30 13F Dexcom COM 252131107 19,231 690 3.72 8,212 23.23 0.0710
2021-06-02 2021-03-31 13F Dexcom COM 252131107 18,541 1,299 7.53 6,664 4.53 0.0604
2021-02-05 2020-12-31 13F DexCom COM 252131107 17,242 91 0.53 6,375 -9.83 0.0614
2020-10-15 2020-09-30 13F DexCom COM 252131107 17,151 -262 -1.50 7,070 0.14 0.0771
2020-07-27 2020-06-30 13F DexCom COM 252131107 17,413 -3,278 -15.84 7,060 26.73 0.0822
2020-04-29 2020-03-31 13F DexCom COM 252131107 20,691 1,100 5.61 5,571 29.98 0.0741
2020-02-03 2019-12-31 13F DexCom COM 252131107 19,591 -655 -3.24 4,286 41.83 0.0450
2019-10-24 2019-09-30 13F DexCom COM 252131107 20,246 -1,217 -5.67 3,022 -6.03 0.0336
2019-07-19 2019-06-30 13F DexCom COM 252131107 21,463 125 0.59 3,216 26.56 0.0363
2019-04-19 2019-03-31 13F DexCom COM 252131107 21,338 -1,207 -5.35 2,541 -5.92 0.0293
2019-01-28 2018-12-31 13F DexCom COM 252131107 22,545 -663 -2.86 2,701 -18.62 0.0338
2018-10-22 2018-09-30 13F DexCom COM 252131107 23,208 1,899 8.91 3,319 63.98 0.0358
2018-07-26 2018-06-30 13F DexCom COM 252131107 21,309 -993 -4.45 2,024 22.37 0.0229
2018-04-18 2018-03-31 13F DexCom COM 252131107 22,302 508 2.33 1,654 32.21 0.0186
2018-01-18 2017-12-31 13F DexCom COM 252131107 21,794 5,303 32.16 1,251 55.02 0.0135
2017-10-23 2017-09-30 13F DEXCOM COMMON STOCK 252131107 16,491 370 2.30 807 -31.61 0.0092
2017-07-31 2017-06-30 13F DEXCOM COMMON STOCK 252131107 16,121 -5,747 -26.28 1,180 -36.32 0.0138
2017-05-02 2017-03-31 13F DEXCOM COMMON STOCK 252131107 21,868 -16,457 -42.94 1,853 -19.01 0.0219
2017-02-03 2016-12-31 13F DEXCOM COMMON STOCK 252131107 38,325 13,125 52.08 2,288 3.58 0.0280
2016-10-28 2016-09-30 13F DEXCOM COMMON STOCK 252131107 25,200 25,200 2,209 0.0285
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.